Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6423612rdf:typepubmed:Citationlld:pubmed
pubmed-article:6423612lifeskim:mentionsumls-concept:C0019348lld:lifeskim
pubmed-article:6423612lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6423612lifeskim:mentionsumls-concept:C0024337lld:lifeskim
pubmed-article:6423612lifeskim:mentionsumls-concept:C0681904lld:lifeskim
pubmed-article:6423612pubmed:issue5lld:pubmed
pubmed-article:6423612pubmed:dateCreated1984-5-11lld:pubmed
pubmed-article:6423612pubmed:abstractTextTo test the effect of lysine supplementation on herpes infection, 1543 subjects were surveyed by questionnaire after a six-month trial period. The study included subjects with cold sores, canker sores, and genital herpes. Of these, 54% had been diagnosed and treated by a physician. The results showed that the average dosage used was 936 mg of lysine daily. Eighty-four per cent of those surveyed said that lysine supplementation prevented recurrence or decreased the frequency of herpes infection. Whereas 79% described their symptoms as severe or intolerable without lysine, only 8% used these terms when taking lysine. Without lysine, 90% indicated that healing took six to 15 days, but with lysine 83% stated that lesions healed in five days or less. Overall, 88% considered supplemental lysine an effective form of treatment for herpes infection.lld:pubmed
pubmed-article:6423612pubmed:languageenglld:pubmed
pubmed-article:6423612pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6423612pubmed:citationSubsetIMlld:pubmed
pubmed-article:6423612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6423612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6423612pubmed:statusMEDLINElld:pubmed
pubmed-article:6423612pubmed:monthNovlld:pubmed
pubmed-article:6423612pubmed:issn0305-7453lld:pubmed
pubmed-article:6423612pubmed:authorpubmed-author:GriffithR SRSlld:pubmed
pubmed-article:6423612pubmed:authorpubmed-author:WalshD EDElld:pubmed
pubmed-article:6423612pubmed:authorpubmed-author:BehforoozAAlld:pubmed
pubmed-article:6423612pubmed:issnTypePrintlld:pubmed
pubmed-article:6423612pubmed:volume12lld:pubmed
pubmed-article:6423612pubmed:ownerNLMlld:pubmed
pubmed-article:6423612pubmed:authorsCompleteYlld:pubmed
pubmed-article:6423612pubmed:pagination489-96lld:pubmed
pubmed-article:6423612pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:meshHeadingpubmed-meshheading:6423612-...lld:pubmed
pubmed-article:6423612pubmed:year1983lld:pubmed
pubmed-article:6423612pubmed:articleTitleSubjective response to lysine in the therapy of herpes simplex.lld:pubmed
pubmed-article:6423612pubmed:publicationTypeJournal Articlelld:pubmed